SAN FRANCISCO, Jan. 19, 2023 /PRNewswire/ -- Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced that the first patient has been enrolled in the clinical trial TLL018-205, a Phase II, randomized, double-blind, placebo-controlled study to...
News Ticker
- [ January 30, 2023 ] STAT+: Gene therapy can transform life for people with hemophilia. But some patients don’t want it. News
- [ January 30, 2023 ] Roche’s Genentech debuts next iteration of MS campaign, highlights experiences in Black community News
- [ January 30, 2023 ] Scientist: Protein Purification – Celltheon – Union City, CA San Francisco Biotech Jobs
- [ January 30, 2023 ] AI predicts global warming will exceed 1.5 degrees in 2030s News
- [ January 30, 2023 ] Oracle executive Troy Tazbaz named new FDA director of digital health News
Copyright © 2022 Biotech Networks, LLC
